Protalix BioTherapeutics (PLX) News Today → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free PLX Stock Alerts $1.17 -0.06 (-4.88%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20, 2024 | americanbankingnews.comResearch Analysts Offer Predictions for Protalix BioTherapeutics, Inc.'s FY2024 Earnings (NYSE:PLX)May 15, 2024 | finance.yahoo.comPLX: First Quarter UpdateMay 13, 2024 | finance.yahoo.comProtalix BioTherapeutics Inc (PLX) Q1 2024 Earnings Call Transcript Highlights: Navigating ...May 12, 2024 | investing.comEarnings call: Protalix BioTherapeutics Q1 2024 financial resultsMay 11, 2024 | finance.yahoo.comProtalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2024 Earnings Call TranscriptMay 10, 2024 | investorplace.comPLX Stock Earnings: Protalix BioTherapeutics Misses EPS, Misses Revenue for Q1 2024May 10, 2024 | msn.comNovavax, Macrogenics, Biofrontera among healthcare moversMay 10, 2024 | msn.comStocks See Support from Higher Chip Stocks and Earnings OptimismMay 10, 2024 | markets.businessinsider.comProtalix BioTherapeutics Inc. Q1 Loss Increases, Misses EstimatesMay 10, 2024 | prnewswire.comProtalix BioTherapeutics Reports First Quarter 2024 Financial and Business ResultsMay 9, 2024 | markets.businessinsider.comProtalix BioTherapeutics earnings: here's what Wall Street expectsMay 3, 2024 | finance.yahoo.comProtalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024March 16, 2024 | seekingalpha.comProtalix BioTherapeutics, Inc. (PLX) Q4 2023 Earnings Call TranscriptMarch 16, 2024 | uk.investing.comEarnings call: Protalix BioTherapeutics reports fiscal year 2023 resultsMarch 15, 2024 | marketbeat.comProtalix BioTherapeutics (NYSE:PLX) Downgraded to "Hold" at StockNews.comStockNews.com cut Protalix BioTherapeutics from a "buy" rating to a "hold" rating in a research note on Friday.March 15, 2024 | ca.finance.yahoo.comProduction cuts, geopolitical tensions drive oil rallyMarch 15, 2024 | finance.yahoo.comProtalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comPLX: Elfabrio Geographic ExpansionMarch 14, 2024 | finanznachrichten.deProtalix BioTherapeutics, Inc.: Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business ResultsMarch 14, 2024 | finance.yahoo.comProtalix BioTherapeutics Inc Reports Revenue Growth and Net Income Gain in FY 2023March 14, 2024 | prnewswire.comProtalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business ResultsMarch 13, 2024 | markets.businessinsider.comHere's what Wall Street expects from Protalix BioTherapeutics's earnings reportMarch 13, 2024 | benzinga.comEarnings Preview: Protalix BioTherapeuticsMarch 13, 2024 | marketbeat.comProtalix BioTherapeutics (PLX) Scheduled to Post Quarterly Earnings on ThursdayProtalix BioTherapeutics (NYSE:PLX) will be releasing earnings on Thursday, March 14, Yahoo Finance reports.March 9, 2024 | edition.cnn.comProtalix Biotherapeutics, Inc.March 7, 2024 | finance.yahoo.comProtalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024February 25, 2024 | marketbeat.comProtalix BioTherapeutics (PLX) Set to Announce Quarterly Earnings on MondayProtalix BioTherapeutics (NYSE:PLX) will be releasing earnings on Monday, February 26, Yahoo Finance reports.February 23, 2024 | prnewswire.comProtalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor ConferenceFebruary 17, 2024 | ca.finance.yahoo.comPLX Mar 2024 1.500 callFebruary 2, 2024 | msn.comAbeona issues update on FDA market application for pz-celJanuary 25, 2024 | entrepreneur.comWill These 3 Biotech Stocks Make Gains in 2024?December 26, 2023 | finance.yahoo.comProtalix BioTherapeutics Issues 2024 Letter to StockholdersDecember 25, 2023 | marketbeat.comProtalix BioTherapeutics (NYSE:PLX) Upgraded by StockNews.com to BuyStockNews.com upgraded Protalix BioTherapeutics from a "hold" rating to a "buy" rating in a research report on Monday.December 15, 2023 | benzinga.comProtalix BioTherapeutics Stock (AMEX:PLX) Insider TradesDecember 15, 2023 | marketbeat.comProtalix BioTherapeutics (NYSE:PLX) Stock Rating Lowered by StockNews.comStockNews.com cut shares of Protalix BioTherapeutics from a "buy" rating to a "hold" rating in a research note on Friday.November 7, 2023 | finance.yahoo.comPLX: More Regulatory ApprovalsNovember 7, 2023 | finance.yahoo.comProtalix BioTherapeutics, Inc. (AMEX:PLX) Q3 2023 Earnings Call TranscriptNovember 6, 2023 | msn.comAmerican Well, Protalix BioTherapeutics among healthcare moversNovember 6, 2023 | msn.comProtalix BioTherapeutics GAAP EPS of -$0.04 beats by $0.03, revenue of $10.35M beats by $2.71MNovember 6, 2023 | washingtonpost.comProtalix: Q3 Earnings SnapshotNovember 6, 2023 | markets.businessinsider.comProtalix BioTherapeutics Inc. Q3 loss drops in line with estimatesNovember 6, 2023 | finance.yahoo.comProtalix BioTherapeutics Reports Third Quarter 2023 Financial and Business ResultsNovember 6, 2023 | finance.yahoo.comProtalix BioTherapeutics Inc (PLX) Reports Q3 2023 Financial ResultsNovember 3, 2023 | msn.comProtalix BioTherapeutics Q3 Earnings PreviewOctober 31, 2023 | theglobeandmail.comUpcoming Earnings Release Paired With Price Target Raise Sends Stock SoaringOctober 30, 2023 | finance.yahoo.comProtalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023October 20, 2023 | msn.comPalatin Technologies, Protalix BioTherapeutics, Arcutis among healthcare moversOctober 9, 2023 | finance.yahoo.comProtalix BioTherapeutics Issues Statement Regarding Security Situation in IsraelSeptember 12, 2023 | markets.businessinsider.comProtalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As ChairmanSeptember 12, 2023 | finance.yahoo.comProtalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors Get Protalix BioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now PLX Media Mentions By Week PLX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PLX News Sentiment▼-0.500.81▲Average Medical News Sentiment PLX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PLX Articles This Week▼01▲PLX Articles Average Week Get Protalix BioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AlloVir News Atara Biotherapeutics News Cognition Therapeutics News Elutia News bluebird bio News BioAtla News Instil Bio News DBV Technologies News CEL-SCI News LENZ Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:PLX) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeBill Clinton Backing Biden Replacement???The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
